Antibody molecules elicited with rationally designed transition-state analo
gs catalyze numerous reactions, including many that cannot be achieved by s
tandard chemical methods. Although relatively primitive when compared with
natural enzymes, these catalysts are valuable tools for probing the origins
and evolution of biological catalysis. Mechanistic and structural analyses
of representative antibody catalysts, generated with a variety of strategi
es for several different reaction types, suggest that their modest efficien
cy is a consequence of imperfect hapten design and indirect selection. Deve
lopment of improved transition-stare analogs, refinements in immunization a
nd screening protocols, and elaboration of general strategies for augmentin
g the efficiency of first-generation catalytic antibodies are identified as
evident, but difficult, challenges Tor this field. Rising to these challen
ges and more successfully integrating programmable design with the selectiv
e forces of biology will enhance our understanding of enzymatic catalysis.
Further, it should yield useful protein catalysts for an enhanced range of
practical applications in chemistry and biology.